Announcing New Tobacco Product Review Decisions

This Week in CTP - Updates from the Center for Tobacco Products Today, FDA issued additional tobacco product review decisions, denying the marketing and sale of two new tobacco product through the substantial equivalence review path. The products were found to be “not substantially equivalent (NSE)” to the predicate products to which they were compared. The products under review were not on the market and cannot be introduced into the market. You can find more information about these decisions on our Tobacco Product Marketing Orders webpage. FDA has also added a new feature to our Tobacco Product Marketing Orders webpage. Site visitors can now sign-up to receive updates about substantial equivalence orders. By signing up, you will receive notifications whenever we update the content on that page. Visit the Tobacco Product Marketing Orders webpage to sign up today!   You are subscribed to FDA Tobacco Products Email Updates. Subscriber Services: Manage Preferences | Unsubscribe | Help with this service If you have questions, please email AskCTP@fda.hhs.gov or call 1-877-CTP-1373. Food and Drug Administration | 9200 Corporate Blvd.  | Rockville, MD 20850  | www.fda.gov/tobacco This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420